New Horizon Health Limited 6606.HK Stock
New Horizon Health Limited Price Chart
New Horizon Health Limited 6606.HK Financial and Trading Overview
| New Horizon Health Limited stock price | 14.14 HKD |
| Previous Close | 29.75 HKD |
| Open | 29.9 HKD |
| Bid | 30.3 HKD x N/A |
| Ask | 30.4 HKD x N/A |
| Day's Range | 29.3 - 30.9 HKD |
| 52 Week Range | 12.7 - 38.95 HKD |
| Volume | 3.1M HKD |
| Avg. Volume | 2.47M HKD |
| Market Cap | 13.91B HKD |
| Beta (5Y Monthly) | 1.279448 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.24 HKD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 60.07 HKD |
6606.HK Valuation Measures
| Enterprise Value | 11.7B HKD |
| Trailing P/E | N/A |
| Forward P/E | 57.358494 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 18.18313 |
| Price/Book (mrq) | 6.1613293 |
| Enterprise Value/Revenue | 15.291 |
| Enterprise Value/EBITDA | -67.991 |
Trading Information
New Horizon Health Limited Stock Price History
| Beta (5Y Monthly) | 1.279448 |
| 52-Week Change | 95.98% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 38.95 HKD |
| 52 Week Low | 12.7 HKD |
| 50-Day Moving Average | 28.25 HKD |
| 200-Day Moving Average | 24.32 HKD |
6606.HK Share Statistics
| Avg. Volume (3 month) | 2.47M HKD |
| Avg. Daily Volume (10-Days) | 1.6M HKD |
| Shares Outstanding | 457.54M |
| Float | 275.36M |
| Short Ratio | N/A |
| % Held by Insiders | 30.79% |
| % Held by Institutions | 40.47% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -10.35% |
| Operating Margin (ttm) | -24.12% |
| Gross Margin | 84.47% |
| EBITDA Margin | -22.48% |
Management Effectiveness
| Return on Assets (ttm) | -4.67% |
| Return on Equity (ttm) | -3.78% |
Income Statement
| Revenue (ttm) | 764.96M HKD |
| Revenue Per Share (ttm) | 1.81 HKD |
| Quarterly Revenue Growth (yoy) | 219.40% |
| Gross Profit (ttm) | 646.17M HKD |
| EBITDA | -172040000 HKD |
| Net Income Avi to Common (ttm) | -79238000 HKD |
| Diluted EPS (ttm) | -0.23 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.34B HKD |
| Total Cash Per Share (mrq) | 3.12 HKD |
| Total Debt (mrq) | 244.99M HKD |
| Total Debt/Equity (mrq) | 11.55 HKD |
| Current Ratio (mrq) | 8.796 |
| Book Value Per Share (mrq) | 4.934 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -412537984 HKD |
| Levered Free Cash Flow (ttm) | -257441248 HKD |
Profile of New Horizon Health Limited
| Country | Hong Kong |
| State | N/A |
| City | Hangzhou |
| Address | T1 Building |
| ZIP | 310052 |
| Phone | 86 57 1811 07210 |
| Website | https://ir.newhorizonbio.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 878 |
New Horizon Health Limited, an investment holding company, engages in the research and development of screening products for colorectal, cervical, and other types of cancer in the People's Republic of China. Its products include ColoClear, an early screening products for colon cancer; Pupu Tube, a fecal occult blood self test product; and UU Tube, a helicobacter pylori self-test products. The company is also involved in the research and development of medical diagnostic technology; provision of technical services, transfers, and consultation; and medical services, as well as financing services; manufacturing and sales of medical and laboratory equipment, and fecal occult blood test kits; and technological import and export activities. The company was founded in 2015 and is headquartered in Hangzhou, China.
Q&A For New Horizon Health Limited Stock
What is a current 6606.HK stock price?
New Horizon Health Limited 6606.HK stock price today per share is 14.14 HKD.
How to purchase New Horizon Health Limited stock?
You can buy 6606.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for New Horizon Health Limited?
The stock symbol or ticker of New Horizon Health Limited is 6606.HK.
Which industry does the New Horizon Health Limited company belong to?
The New Horizon Health Limited industry is Medical Devices.
How many shares does New Horizon Health Limited have in circulation?
The max supply of New Horizon Health Limited shares is 448.72M.
What is New Horizon Health Limited Price to Earnings Ratio (PE Ratio)?
New Horizon Health Limited PE Ratio is 58.91666800 now.
What was New Horizon Health Limited earnings per share over the trailing 12 months (TTM)?
New Horizon Health Limited EPS is 0.24 HKD over the trailing 12 months.
Which sector does the New Horizon Health Limited company belong to?
The New Horizon Health Limited sector is Healthcare.
New Horizon Health Limited 6606.HK included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Nasdaq EM Plus Korea Small Cap NQEMKRSCGBP | 1476.35 GBP 1888.16 USD |
<0.01
|
— — | 1476.35 GBP 1888.16 USD | 1476.35 GBP 1888.16 USD | — - | — — |
- {{ link.label }} {{link}}